A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer

Clinical trial NCT07347951 · RECRUITING

Trial details

NCT number: NCT07347951
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer (LARC)

Start date: 2025-12-01
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.